Brind.

Adaptive Biotechnologies reported results and integrated its clonoSEQ technology into Flatiron’s OncoEMR platform.

3 reports, 1 independent Updated Jul 1

Gone quiet

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Adaptive Biotechnologies reported results and integrated its clonoSEQ technology into Flatiron’s OncoEMR platform.

Who's involved

What this event is mainly about

Adaptive Biotechnologies Flatiron

Keep exploring

The entities involved

Adaptive Biotechnologies
company in Seattle, United States
- Adaptive Biotechnologies presented findings at the IMS meeting in Glasgow on September 25, 2026.Fri 14:06
Flatiron
Slovak company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 6GlobeNewswireAdaptive Biotechnologies Reports Second Quarter 2025 Financial Results SEATTLE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a c
Jul 1Unknown outlet

1 more outlet ran the same wire story

Jul 1manilatimes.net